Synthesis, antitumor evaluation, and in silico investigation of pyridine-based pyrimidotriazine and triazolopyrimidine derivatives as potential EGFR-targeted anticancer agents
RSC Advances · 2026 · 16 (49) · 66903-66921
DOI: 10.1039/d6ra07493f ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Advances, 2026. Verfasst von Sayed K Ramadan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry Department, Faculty of Science, Ain Shams University Cairo 11566 Egypt sayed.karam2008@sci.asu.edu.eg. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Newly synthesized pyridine-based triazolopyrimidines exhibited potent antiproliferative activity, while indole-bearing analog emerged as promising EGFR-directed candidate, supported by EGFR kinase inhibition, molecular docking, and ADME studies.
Autor:innen und Institutionen
- Chemistry Department, Faculty of Science, Ain Shams University Cairo 11566 Egypt sayed.karam2008@sci.asu.edu.eg.
- Petrochemicals Department, Egyptian Petroleum Research Institute (EPRI) Cairo 11727 Egypt.
- Processes Design and Development Department, Egyptian Petroleum Research Institute (EPRI) Cairo 11727 Egypt.
- Department of Chemistry, Faculty of Science, Islamic University of Madinah Madinah 42351 Saudi Arabia smgomha@iu.edu.sa.
- Department of Chemistry, Faculty of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU) Riyadh 11623 Saudi Arabia.
ORCID-Profile: Sayed K Ramadan, Mohamed A Hegazy, Sobhi M Gomha
Zitieren
APA
Ramadan, S. K., Abdelrahman, A. H., Hegazy, M. A., Labena, A., Gomha, S. M., Zaki, M. E. A., & Azab, M. E. (2026). Synthesis, antitumor evaluation, and in silico investigation of pyridine-based pyrimidotriazine and triazolopyrimidine derivatives as potential EGFR-targeted anticancer agents. RSC Advances, 16(49), 66903-66921. https://doi.org/10.1039/d6ra07493f
Vancouver
Ramadan SK, Abdelrahman AH, Hegazy MA, Labena A, Gomha SM, Zaki MEA, et al. Synthesis, antitumor evaluation, and in silico investigation of pyridine-based pyrimidotriazine and triazolopyrimidine derivatives as potential EGFR-targeted anticancer agents. RSC Advances. 2026;16(49):66903-66921. doi:10.1039/d6ra07493f
BibTeX
@article{Ramadan2026,
author = {Ramadan, Sayed K and Abdelrahman, Ali H and Hegazy, Mohamed A and Labena, Ahmed and Gomha, Sobhi M and Zaki, Magdi E A and Azab, Mohammad E},
title = {Synthesis, antitumor evaluation, and in silico investigation of pyridine-based pyrimidotriazine and triazolopyrimidine derivatives as potential EGFR-targeted anticancer agents},
journal = {RSC Advances},
year = {2026},
volume = {16},
number = {49},
pages = {66903--66921},
doi = {10.1039/d6ra07493f}
}
EUVIMED